Cargando…

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue

PURPOSE: To investigate the feasibility of neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy (IMRT) for intracranial invasion nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: From June 2007 to January 2012, 32 patients with intracranial invasion NPC treated with TPF (doc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Xiaoshuang, Chang, Xi, Gao, Yunsheng, Hu, Chaosu, Kong, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874595/ https://www.ncbi.nlm.nih.gov/pubmed/24083351 http://dx.doi.org/10.1186/1748-717X-8-226

Ejemplares similares

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
por: Niu, Xiaoshuang, et al.
Publicado: (2021)

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Xie, Dehuan, et al.
Publicado: (2019)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era
por: Niu, Xiaoshuang, et al.
Publicado: (2022)

Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wu, Mingyao, et al.
Publicado: (2018)

A Fast Online Replanning Algorithm Based on Intensity Field Projection for Adaptive Radiotherapy
por: Liu, Xiaomeng, et al.
Publicado: (2020)

Induction Chemotherapy Combined With Intensity-Modulated Radiotherapy for 129 Nasopharyngeal Carcinoma Patients With Synchronous Metastases: A Retrospective Study
por: Ni, Mengshan, et al.
Publicado: (2021)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma
por: Xue, Fen, et al.
Publicado: (2017)

Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma
por: Gai, Xiujuan, et al.
Publicado: (2017)

Adaptive replanning intensity-modulated radiotherapy for choroidal metastasis of breast cancer using optical coherence tomography
por: INOUE, Toshihiko, et al.
Publicado: (2014)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2018)

Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
por: Shueng, Pei-Wei, et al.
Publicado: (2011)

Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
por: Le, Ziyu, et al.
Publicado: (2017)

Comparing Long-Term Survival and Late Toxicities of Different Sequential Chemotherapy Regimens with Intensity-Modulated Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Wu, Mingyao, et al.
Publicado: (2020)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

Radiotherapy for Head and Neck Cancer: Evaluation of Triggered Adaptive Replanning in Routine Practice
por: Figen, Metin, et al.
Publicado: (2020)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Replanning Criteria and Timing Definition for Parotid Protection-Based Adaptive Radiation Therapy in Nasopharyngeal Carcinoma
por: Yao, Wei-Rong, et al.
Publicado: (2015)

Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2014)

Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study
por: Yan, DanFang, et al.
Publicado: (2013)

Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol “Best for Adaptive Radiotherapy” in Head and Neck Cancer
por: Bak, Bartosz, et al.
Publicado: (2022)

Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China
por: Zhou, Xiate, et al.
Publicado: (2023)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
por: Kong, Fangfang, et al.
Publicado: (2023)

The impact of body composition parameters on severe toxicities in patients with locoregionally advanced nasopharyngeal carcinoma undergoing neoadjuvant chemotherapy
por: Xing, Xing, et al.
Publicado: (2021)

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study
por: Niu, Xiaoshuang, et al.
Publicado: (2023)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
por: Chang, Hui, et al.
Publicado: (2019)

Individualized Concurrent Chemotherapy for Patients with Stage III–IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
por: Ji, Pengjie, et al.
Publicado: (2023)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
por: Wee, Chan Woo, et al.
Publicado: (2015)

Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy
por: Chen, Chuanben, et al.
Publicado: (2017)

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2020)

Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland？
por: Niu, Xiaoshuang, et al.
Publicado: (2023)

Task Roadmaps: Speeding up Task Replanning
por: Lager, Anders, et al.
Publicado: (2022)

Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Corrigendum: Task Roadmaps: Speeding Up Task Replanning
por: Lager, Anders, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy
por: Du, Xiao-Jing, et al.
Publicado: (2015)

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_84geh40tf72b8j4ldv33n4o31i